Hetlioz الاتحاد الأوروبي - الإيطالية - EMA (European Medicines Agency)

hetlioz

vanda pharmaceuticals netherlands b.v. - tasimelteon - disturbi del sonno, ritmo circadiano - psicolettici - hetlioz è indicato per il trattamento del disturbo del sonno non-24 ore (non-24) in adulti totalmente ciechi.

Kalcipos-D3 500/800 Compresse rivestite con film سويسرا - الإيطالية - Swissmedic (Swiss Agency for Therapeutic Products)

kalcipos-d3 500/800 compresse rivestite con film

viatris pharma gmbh - cholecalciferolum, calcio - compresse rivestite con film - cholecalciferolum 800 u.i., calcii carbonas 1261 mg corresp. calcium 500 mg, maltodextrinum, carmellosum natricum conexum, silica colloidalis anhydrica, magnesii stearas, triglycerida media, amylum modificatum, saccharum 1.75 mg, silica colloidalis anhydrica, e 301, e 307, Überzug: hypromellosum, macrogolum 6000, paraffinum solidum syntheticum, pro compresso obducto corresp. natrium 3.2 mg. - di calcio e di vitamina d integratore - synthetika

Libmeldy الاتحاد الأوروبي - الإيطالية - EMA (European Medicines Agency)

libmeldy

orchard therapeutics (netherlands) bv - atidarsagene autotemcel - leukodystrophy, metachromatic - altri farmaci sul sistema nervoso - libmeldy is indicated for the treatment of metachromatic leukodystrophy (mld) characterized by biallelic mutations in the arysulfatase a (arsa) gene leading to a reduction of the arsa enzymatic activity:in children with late infantile or early juvenile forms, without clinical manifestations of the disease,in children with the early juvenile form, with early clinical manifestations of the disease, who still  have the ability to walk independently and before the onset of cognitive decline.